Simfibrate

This classification denotes an anti-lipidemic agent with the molecular formula C23H26Cl2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L2R75RQX26, chemically known as 1,3-propanediol bis(alpha-(p-chlorophenoxy)isobutyrate) but generally known as simfibrate, which bears US NIH Compound Identifier 5217. European Medicines Agency schedules Simfibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10527MIG. The term SIMFIBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules simfibrate in its Anatomical Therapeutic Chemical (ATC) Classification. SIMFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule simfibrate under HS 29189900 and SITC 51396. As of Q4 2014, SIMFIBRATE remains the US FDA Preferred Term for this commodity. Simfibrate bears US NLM identifiers UMLS ID C0074551 and NCI Concept Code C72998. SMILES: Clc1ccc(OC(C(=O)OCCCOC(=O)C(Oc2ccc(Cl)cc2)(C)C)(C)C)cc1.